Myers, E. L., Liu, J., Shearer, S. M., Myers, S. A., Schneider, M., Hoimes, C., & Whitley, M. J. (2025). Recognition and management of adverse cutaneous reactions in patients on enfortumab vedotin and pembrolizumab in the inpatient setting. JAAD Case Rep, 58, 85–92. https://doi.org/10.1016/j.jdcr.2024.12.037

Myers, Emma L., Jessica Liu, Sabrina M. Shearer, Sarah A. Myers, Michelle Schneider, Christopher Hoimes, and Melodi Javid Whitley. “Recognition and management of adverse cutaneous reactions in patients on enfortumab vedotin and pembrolizumab in the inpatient setting.” JAAD Case Rep 58 (April 2025): 85–92. https://doi.org/10.1016/j.jdcr.2024.12.037.

Myers EL, Liu J, Shearer SM, Myers SA, Schneider M, Hoimes C, et al. Recognition and management of adverse cutaneous reactions in patients on enfortumab vedotin and pembrolizumab in the inpatient setting. JAAD Case Rep. 2025 Apr;58:85–92.

Myers, Emma L., et al. “Recognition and management of adverse cutaneous reactions in patients on enfortumab vedotin and pembrolizumab in the inpatient setting.” JAAD Case Rep, vol. 58, Apr. 2025, pp. 85–92. Pubmed, doi:10.1016/j.jdcr.2024.12.037.

Myers EL, Liu J, Shearer SM, Myers SA, Schneider M, Hoimes C, Whitley MJ. Recognition and management of adverse cutaneous reactions in patients on enfortumab vedotin and pembrolizumab in the inpatient setting. JAAD Case Rep. 2025 Apr;58:85–92.